Published Literature Bibliography

Ratishvili T, Quach HQ, Haralambieva IH, Suryawanshi YR, Ovsyannikova IG, Kennedy RB, Poland GA.

A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides.

Vaccine. 2024 Jan 12;42(2):162-174. doi: 10.1016/j.vaccine.2023.12.024. Epub 2023 Dec 16.

PMID: 38105139

Quach HQ, Ovsyannikova IG, Poland GA, Kennedy RB.

Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA.

J Immunol Methods. 2022 Jun;505:113275. doi: 10.1016/j.jim.2022.113275. Epub 2022 Apr 16.

PMID: 35439529

Quach HQ, Ovsyannikova IG, Poland GA, Kennedy RB.

Evaluating immunogenicity of pathogen-derived T-cell epitopes to design a peptide-based smallpox vaccine.

Sci Rep. 2022 Sep 13;12(1):15401. doi: 10.1038/s41598-022-19679-3.

PMID: 36100624

Poland GA, Ovsyannikova IG, Kennedy RB.

The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.

Vaccine. 2021 Jul 13;39(31):4239-4241. doi: 10.1016/j.vaccine.2021.06.028. Epub 2021 Jun 14.

PMID: 34167836

Crooke SN, Ovsyannikova IG, Kennedy RB, Poland GA.

Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects.

PLoS One. 2021 Jun 2;16(6):e0252198. doi: 10.1371/journal.pone.0252198. eCollection 2021.

PMID: 34077451

Ovsyannikova IG, Johnson KL, Bergen HR 3rd, Poland GA.

Mass spectrometry and peptide-based vaccine development.

Clin Pharmacol Ther. 2007 Dec;82(6):644-52. doi: 10.1038/sj.clpt.6100389. Epub 2007 Oct 31.

PMID: 17971823

Ovsyannikova IG, Johnson KL, Muddiman DC, Vierkant RA, Poland GA.

Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.

J Virol. 2004 Jan;78(1):42-51. doi: 10.1128/jvi.78.1.42-51.2004.

PMID: 14671086